Recent studies have revealed that the v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutation rates are high in certain cancers and the most common is BRAF V600E, with variable mutation rates in different populations [80]. This evidence concerns the gene BRAF and cancer.